Skip to main content
Premium Trial:

Request an Annual Quote

Peter Lundberg, Tony Smith, William Sullivan, Ned Barnholt

Premium

Peter Lundberg has joined Solexa as vice president and chief technical officer, the company announced this week. Lundberg will be responsible for all research and development activities at the company’s Hayward, Calif.-location.

Lundberg most recently served as vice president of DNA platforms R&D at the Applied Biosystems unit of Applera, where he held positions for 20 years.

He received his BS and MS degrees in engineering physics at Chalmers Technical University in Sweden. He holds an MBA, with a concentration in finance, from the University of Connecticut.

Solexa also announced that Tony Smith, who had served as the chief technology officer of Solexa, Ltd until its merger with Lynx, has been promoted to the role of vice president and chief scientific officer. Smith will continue to be responsible for all research and development activities in the UK and will now be the senior manager in the UK.

Smith was formerly vice president of R&D, UK, at Amersham Biosciences, where he also held R&D positions. Previously, he was an executive director of Gemini Genomics. Smith obtained both his BS in biochemistry and chemistry and his PhD in biochemistry from Nottingham University.


William Sullivan, the president and CEO of Agilent Technologies, will receive an annual salary of $850,000, the company said in a March 1 SEC filing.

Sullivan replaced CEO Ned Barnholt who retired this month. As executive vice president and COO of Agilent, Sullivan had a salary of $650,000.

 

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.